Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1980 Oct;30(1):212–218. doi: 10.1128/iai.30.1.212-218.1980

Separation of Sendai virus glycoproteins by using glutaraldehyde-treated erythrocytes and preparation of monospecific antisera against the glycoproteins.

Y Hosaka
PMCID: PMC551297  PMID: 6254880

Abstract

Sendai virus hemagglutinin-neuraminidase (HN) and fusion (F) glycoproteins, F and HN, were separated from Triton X-100- or Nonidet P-40-solubilized envelopes as unadsorbed and eluted fractions, respectively, by using glutaralde-hyde-treated chicken erythrocytes. These separated glycoproteins were biologically active. Monospecific antisera (in terms of monoreactivity to virus glycoproteins in gel diffusion precipitation patterns) were prepared by using these fractions as immunogens. Anti-HN rabbit serum inhibited all of the viral activities tested (infectivity, neuraminidase, hemagglutinating, and viral hemolysis), whereas anti-F serum definitely inhibited viral hemolysis only, although the two antisera enhanced neutralization in the presence of complement. The advantages and disadvantages of this separation method were discussed.

Full text

PDF
212

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AMINOFF D. Methods for the quantitative estimation of N-acetylneuraminic acid and their application to hydrolysates of sialomucoids. Biochem J. 1961 Nov;81:384–392. doi: 10.1042/bj0810384. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Avery R. J., Niven J. Use of antibodies to purified Newcastle disease virus glycoproteins for strain comparisons and characterizations. Infect Immun. 1979 Dec;26(3):795–801. doi: 10.1128/iai.26.3.795-801.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Fukami Y., Hosaka Y., Yasuda Y., Bonilla J. A. Difference in capacity of Sendai virus envelope components to induce cytotoxic T lymphocytes in primary and secondary immune responses. Infect Immun. 1979 Dec;26(3):815–821. doi: 10.1128/iai.26.3.815-821.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gething M. J., White J. M., Waterfield M. D. Purification of the fusion protein of Sendai virus: analysis of the NH2-terminal sequence generated during precursor activation. Proc Natl Acad Sci U S A. 1978 Jun;75(6):2737–2740. doi: 10.1073/pnas.75.6.2737. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hosaka Y., Fukami Y., Yasuda Y., Bonilla J. A. Complement-dependent antiviral monospecific antibody-mediated lysis of murine cells coated with Sendai virus or its envelope component. Infect Immun. 1980 Feb;27(2):355–363. doi: 10.1128/iai.27.2.355-363.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hosaka Y., Hosokawa Y. Purification of Sendai virions with glutaraldehyde-treated red blood cells. Intervirology. 1977;8(1):1–17. doi: 10.1159/000148872. [DOI] [PubMed] [Google Scholar]
  7. Hosaka Y., Semba T., Fukai K. Artificial assembly of envelope particles of HVJ (Sendai virus). Fusion activity of envelope particles. J Gen Virol. 1974 Dec;25(3):391–404. doi: 10.1099/0022-1317-25-3-391. [DOI] [PubMed] [Google Scholar]
  8. Hosaka Y., Shimizu Y. K. Artificial assembly of envelope particles of HVJ (Sendai virus). I. Assembly of hemolytic and fusion factors from envelopes solubilized by Nonidet P40. Virology. 1972 Sep;49(3):627–639. doi: 10.1016/0042-6822(72)90519-3. [DOI] [PubMed] [Google Scholar]
  9. Hsu M. C., Scheid A., Choppin P. W. Reconstitution of membranes with individual paramyxovirus glycoproteins and phospholipid in cholate solution. Virology. 1979 Jun;95(2):476–491. doi: 10.1016/0042-6822(79)90502-6. [DOI] [PubMed] [Google Scholar]
  10. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  11. Norrby E., Gollmar Y. Identification of measles virus-specific hemolysis-inihibiting antibodies separate from hemagglutination-inhibiting antibodies. Infect Immun. 1975 Feb;11(2):231–239. doi: 10.1128/iai.11.2.231-239.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Orvell C. Identification of paramyxovirus-specific haemolysis-inhibiting antibodies separate from haemagglutinating-inhibiting and neuraminidase-inhibiting antibodies. 1. Sendai virus haemolysis-inhibiting antibodies. Acta Pathol Microbiol Scand B. 1976 Dec;84B(6):441–450. [PubMed] [Google Scholar]
  13. Orvell C., Norrby E. Immunologic properties of purified Sendai virus glycoproteins. J Immunol. 1977 Dec;119(6):1882–1887. [PubMed] [Google Scholar]
  14. Scheid A., Caliguiri L. A., Compans R. W., Choppin P. W. Isolation of paramyxovirus glycoproteins. Association of both hemagglutinating and neuraminidase activities with the larger SV5 glycoprotein. Virology. 1972 Dec;50(3):640–652. doi: 10.1016/0042-6822(72)90418-7. [DOI] [PubMed] [Google Scholar]
  15. Scheid A., Choppin P. W. Isolation and purification of the envelope proteins of Newcastle disease virus. J Virol. 1973 Feb;11(2):263–271. doi: 10.1128/jvi.11.2.263-271.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Scheid A., Choppin P. W. The hemagglutinating and neuraminidase protein of a paramyxovirus: interaction with neuraminic acid in affinity chromatography. Virology. 1974 Nov;62(1):125–133. doi: 10.1016/0042-6822(74)90308-0. [DOI] [PubMed] [Google Scholar]
  17. Seto J. T., Becht H., Rott R. Effect of specific antibodies on biological functions of the envelope components of Newcastle disease virus. Virology. 1974 Oct;61(2):354–360. doi: 10.1016/0042-6822(74)90273-6. [DOI] [PubMed] [Google Scholar]
  18. Shimizu K., Hosaka Y., Shimizu Y. K. Solubilization of envelopes of HVJ (Sendai virus) with alkali-emasol treatment and reassembly of envelope particles with removal of the detergent. J Virol. 1972 May;9(5):842–850. doi: 10.1128/jvi.9.5.842-850.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Shimizu K., Shimizu Y. K., Koama T., Ishida N. Isolation and characterization of two distinct types of HVJ (Sendai virus) spikes. Virology. 1974 Nov;62(1):90–101. doi: 10.1016/0042-6822(74)90305-5. [DOI] [PubMed] [Google Scholar]
  20. Urata D. M., Seto J. T. Glycoproteins of Sendai virus: purification and antigenic analysis. Intervirology. 1975;6(2):108–114. doi: 10.1159/000149462. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES